Among patients with glioma and IDH mutations, young adults have significantly worse survival outcomes than other age groups, researchers say.
According to Dr Mary Jane Lim-Fat of Sunnybrook Health Science Center in Toronto, Canada, the prognostic significance of IDH mutations in younger patients with glioma is not fully understood.